{"data":{"id":"us-in/ic-16-18-2-244.8","jurisdiction":"us-in","citation":"IC 16-18-2-244.8","heading":"\"Neonatal abstinence syndrome\" and \"NAS\"","body":"Sec. 244.8. \"Neonatal abstinence syndrome\" and \"NAS\", for purposes of IC 16-19-16, refer to the various adverse effects that occur in a newborn infant who was exposed to addictive illegal or prescription drugs while in the mother's womb.","path":["TITLE 16. HEALTH","ARTICLE 18. GENERAL PROVISIONS AND DEFINITIONS","Chapter 2. Definitions"],"source_url":"https://iga.in.gov/ic/2026/Title_16.html#16-18-2-244.8","current_through":"2026","vintage":"2026","retrieved_at":"2026-09-11T20:02:18Z","sha256":"7b74d13373fc491e55f15752305c44ec865efdf9b48b3911d4a08c0ce28d04ea","source_id":"us-in","stale":false,"prev":"us-in/ic-16-18-2-244.6","next":"us-in/ic-16-18-2-245"},"notice":"GroundRules: Original legal text. Not legal advice."}